Diphen and Rheumatoid lung - a phase IV clinical study of FDA data

Summary:

Rheumatoid lung is reported as a side effect among people who take Diphen (diphenhydramine hydrochloride), especially for people who are female, 40-49 old, also take Gravol, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Rheumatoid lung when taking Diphen. It is created by eHealthMe based on reports of 113,958 people who have side effects when taking Diphen from the FDA, and is updated regularly.

What is Diphen?

Diphen has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 115,432 Diphen users. Check the latest studies of Diphen.

What is Rheumatoid lung?

Rheumatoid lung (blockage of the small airways of the lung associated with rheumatoid arthritis) is found to be associated with 144 drugs and 148 conditions by eHealthMe. Check the latest studies of Rheumatoid lung.

On Jul, 16, 2026

113,958 people reported to have side effects when taking Diphen.
Among them, 82 people (0.07%) have Rheumatoid lung.

Among these 82 people:

What is the gender of people who have Rheumatoid lung when taking Diphen? *

female: 70.91 %
male: 29.09 %

What is the age of people who have Rheumatoid lung when taking Diphen? *

What are other drugs people take besides Diphen? *

What are other side effects people have besides Rheumatoid lung? *

Joint Pain: 76 people, 92.68%
Drug Ineffective: 75 people, 91.46%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 75 people, 91.46%
Infusion Related Reaction: 71 people, 86.59%
Joint Swelling: 71 people, 86.59%
Headache (pain in head): 69 people, 84.15%
Nausea (feeling of having an urge to vomit): 68 people, 82.93%
General Physical Health Deterioration (weak health status): 67 people, 81.71%
Fatigue (feeling of tiredness): 67 people, 81.71%
Mobility Decreased (ability to move is reduced): 66 people, 80.49%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 82 people, 100.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 60 people, 73.17%
Adenomatous Polyposis Coli ((fap) is an inherited condition in which numerous polyps form mainly in the epithelium of the large intestine): 60 people, 73.17%
Psoriasis (immune-mediated disease that affects the skin): 57 people, 69.51%
Rashes (redness): 5 people, 6.10%
Spondyloarthropathy (any joint disease of the vertebral column): 2 people, 2.44%

* Approximation only. Some reports may have incomplete information.

Do you take Diphen and have Rheumatoid lung?

- Check whether Rheumatoid lung is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diphen:

Diphen (115,432 reports)

Rheumatoid lung treatments and more:

Rheumatoid lung (1,517 reports)

Browse all side effects of Diphen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rheumatoid lung:

Rheumatoid lung (144 drugs)

Browse all the conditions that are associated with Rheumatoid lung:

Rheumatoid lung (148 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride (the active ingredients of Diphen) and Diphen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.